Biotech case studies
How our flexible approach helps small and mid sized biopharma clients develop transformative therapies and meet milestones to market
Discover our expertise by exploring our biotech case studies and see how we help biotech achieve critical milestones.
Virtual development model
A venture-backed biopharmaceutical company focused on therapies for rare diseases needed to accelerate late-stage development and commercialization. ICON provided technical and commercial assessments, collaborating closely to simplify the development program and develop ePROs and a novel biomarker approach for the rare disease asset.
Success in early phase psoriasis study
A randomised, double-blind, placebo-controlled study on behalf of a biotechnology organisation to evaluate the safety, tolerability, and efficacy of the study drug in subjects with moderate to severe plaque psoriasis.